2nd May 2013 09:58
Director's dealings
Burton-on-Trent, UK - 2 May 2013 Clinigen Group plc ("Clinigen" or the "Company") (AIM: CLIN) was notified on 1 May 2013 that on 1 May 2013, John Hartup, a Non-Executive Director of Clinigen, sold 500,000 Ordinary Shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 265p per Ordinary Share. Following this transaction, Mr Hartup's total interest in the Company is 33,934 Ordinary Shares of 0.1 pence each, representing approximately 0.04 % of the Company's issued share capital.
Contact Details
Clinigen Group plc | Tel: +44 (0) 1283 495 010 |
Peter George, Group Chief Executive Officer | |
Robin Sibson, Chief Financial Officer | |
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
Michael Meade/Freddie Barnfield (Nominated Adviser) | |
James Black/Tom Ballard (Corporate Broking) | |
College Hill (media relations) | Tel: +44 (0) 20 7457 2020 |
Melanie Toyne-Sewell/Stefanie Bacher/Jen Lewis | Email: [email protected] |
Related Shares:
CLIN.L